we implement interventional guidance through imaging

we define new standards in tumor treatments

we care about the cure of cancer



SurgicEye® at a glance



  • News

    SurgicEye takes part in EANM 2022 in Barcelona

    SurgicEye and Crystal Photonics show their solutions for radio guided surgery at EANM (joint booth number 099). The offered products go from gamma probes providing acoustic feedback to 3D imaging and navigation as provided by the declipse®SPECT device. Several devices will be on the booth and you could get hands-on sessions with the team from both companies.   We are looking forward to seeing you soon.

  • News

    World first re-sterilizable DROP-IN gamma probe received CE certification

    SurgicEye congratulates its partners Crystal Photonics GmbH and the Interventional Molecular Imaging laboratory at LUMC for the CE-certification and market introduction of the world first re-sterilizable DROP-IN gamma probe. This new product will enable to port radio-guided surgery to the robotic setup, thus marking a breakthrough in personalized surgery. We look forward to cooperating further with them in this great journey. We are looking forward to integrate the Drop-In probe into our declipse®SPECT framework for further indications. If you are interested in the DROP-IN gamma probe, contact us directly at info@surgiceye.com.

What clinicians say

  • Dr. Sergi Vidal Sicart
    Dr. Sergi Vidal SicartNuclear Medicine Specialist, Hospital Clínic Barcelona, Spain
    The 3D declipseSPECT presents a potential tool in refining the excision margins of tumor in the ROLL technique. The possibility to observe the harvested tissue and the tracer activity within it offers a realistic view of the surgical procedure suited for the operating room.
  • Prof. Dr. René Hornung
    Prof. Dr. René HornungHead of Department of Gynecology Kantonsspital St. Gallen, Switzerland
    The 3D declipse®SPECT Laparoscopy technology opens new horizons to minimally invasive surgery in gynecologic oncology. Sentinel lymph node biopsy during laparoscopic procedures seems to be easily feasible and may in the near future become standard of care for cervical and endometrial cancers.
  • Prof. Dr. Marion Kiechle
    Prof. Dr. Marion KiechleDirector of the Women’s Hospital Klinikum rechts der Isar Munich, Germany
    The declipse®SPECT technology and its intraoperative use for navigated sentinel lymph node dissection enables safer surgeries, and less invasive procedures. This can ensure a high quality outcome for every individual patient.
  • Dr. Omgo E. Nieweg
    Dr. Omgo E. NiewegSurgeon, The Netherlands Cancer Institute Amsterdam, the Netherlands
    The innovative 3D declipseSPECT technology may make the sentinel node biopsy easier and more reliable. New technologies like 3D declipseSPECT will also open up lymphatic mapping to additional cancer types in locations with a more intricate anatomy and cancer types with more complex lymph drainage.


Do you want to know more?

Contact us